Fjarde Ap Fonden Idexx Laboratories Inc Transaction History

Fjarde Ap Fonden

$11.6 Billion
Q3 2025

A detailed history of Fjarde Ap Fonden transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Fjarde Ap Fonden holds 23,592 shares of IDXX stock, worth $16.3 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

23,592

Previous 25,492 7.45%

Holding current value

$16.3 Million

Previous $13.7 Million 10.25%

% of portfolio

0.13%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 28, 2025	SELL	$514.61 - $682.78 $977,759 - $1.3 Million	-1,900 Reduced 7.45%	23,592 $15.1 Million
Q2 2025 Aug 01, 2025	BUY	$361.04 - $536.34 $1.34 Million - $1.98 Million	3,700 Added 16.98%	25,492 $13.7 Million
Q1 2025 May 13, 2025	BUY	$406.29 - $469.04 $325,032 - $375,232	800 Added 3.81%	21,792 $9.15 Million
Q4 2024 Feb 04, 2025	BUY	$406.92 - $495.42 $1.02 Million - $1.24 Million	2,500 Added 13.52%	20,992 $8.68 Million
Q3 2024 Nov 08, 2024	BUY	$455.08 - $517.19 $728,128 - $827,504	1,600 Added 9.47%	18,492 $9.34 Million
Q1 2024 Apr 25, 2024	SELL	$515.08 - $576.87 $515,080 - $576,870	-1,000 Reduced 5.59%	16,892 $9.12 Million
Q3 2023 Oct 23, 2023	SELL	$432.42 - $556.67 $821,598 - $1.06 Million	-1,900 Reduced 9.6%	17,892 $7.82 Million
Q2 2023 Aug 02, 2023	BUY	$450.7 - $503.61 $1.31 Million - $1.46 Million	2,900 Added 17.17%	19,792 $9.94 Million
Q1 2023 May 15, 2023	SELL	$406.01 - $514.59 $487,212 - $617,508	-1,200 Reduced 6.63%	16,892 $8.45 Million
Q4 2022 Feb 14, 2023	SELL	$324.64 - $441.27 $1.74 Million - $2.36 Million	-5,356 Reduced 22.84%	18,092 $7.38 Million
Q2 2022 Aug 11, 2022	BUY	$327.37 - $553.44 $1.01 Million - $1.72 Million	3,100 Added 15.23%	23,448 $8.22 Million
Q1 2022 May 13, 2022	SELL	$466.52 - $631.01 $839,736 - $1.14 Million	-1,800 Reduced 8.13%	20,348 $11.1 Million
Q4 2021 Feb 15, 2022	SELL	$586.54 - $666.48 $249,866 - $283,920	-426 Reduced 1.89%	22,148 $14.6 Million
Q3 2021 Nov 15, 2021	SELL	$621.9 - $705.76 $186,570 - $211,728	-300 Reduced 1.31%	22,574 $14 Million
Q2 2021 Aug 12, 2021	SELL	$486.36 - $637.08 $194,544 - $254,832	-400 Reduced 1.72%	22,874 $14.4 Million
Q1 2021 May 17, 2021	SELL	$465.18 - $551.79 $465,180 - $551,790	-1,000 Reduced 4.12%	23,274 $11.4 Million
Q4 2020 Feb 12, 2021	SELL	$383.85 - $499.87 $1.04 Million - $1.35 Million	-2,700 Reduced 10.01%	24,274 $12.1 Million
Q2 2020 Aug 13, 2020	BUY	$230.66 - $330.16 $549,432 - $786,441	2,382 Added 9.69%	26,974 $8.91 Million
Q1 2020 May 11, 2020	SELL	$182.94 - $290.97 $201,234 - $320,067	-1,100 Reduced 4.28%	24,592 $5.96 Million
Q4 2019 Feb 10, 2020	BUY	$248.66 - $285.01 $124,330 - $142,505	500 Added 1.98%	25,692 $6.71 Million
Q3 2019 Oct 31, 2019	BUY	$260.07 - $289.93 $52,014 - $57,986	200 Added 0.8%	25,192 $6.85 Million
Q2 2019 Jul 17, 2019	SELL	$215.53 - $275.33 $366,401 - $468,061	-1,700 Reduced 6.37%	24,992 $6.88 Million
Q1 2019 Apr 29, 2019	BUY	$178.02 - $225.69 $1.01 Million - $1.28 Million	5,689 Added 27.09%	26,692 $5.97 Million
Q4 2018 Jan 31, 2019	SELL	$176.18 - $248.92 $475,686 - $672,084	-2,700 Reduced 11.39%	21,003 $3.91 Million
Q3 2018 Nov 09, 2018	SELL	$218.82 - $254.46 $297,595 - $346,065	-1,360 Reduced 5.43%	23,703 $5.92 Million
Q2 2018 Jul 12, 2018	SELL	$185.56 - $227.9 $6,123 - $7,520	-33 Reduced 0.13%	25,063 $5.46 Million
Q1 2018 May 07, 2018	SELL	$157.81 - $204.73 $151,024 - $195,926	-957 Reduced 3.67%	25,096 $4.8 Million
Q4 2017 Feb 12, 2018	BUY	$147.68 - $168.37 $665,889 - $759,180	4,509 Added 20.93%	26,053 $4.07 Million
Q3 2017 Nov 07, 2017	BUY	$150.32 - $166.46 $83,878 - $92,884	558 Added 2.66%	21,544 $3.35 Million
Q2 2017 Aug 08, 2017	BUY	N/A	20,986	20,986 $3.39 Million

Others Institutions Holding IDXX

# of Institutions

1,446

Shares Held

73.6M

Call Options Held

252K

Put Options Held

200K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $57.4B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account